Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands
NCT00731536 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2013-10-16
Summary
The purpose of this study is to examine reports of the cancer called hepatosplenic T-cell lymphoma (HSTCL) in the Dutch National Database of Pathology (Pathologisch-Anatomisch Landelijk Geautomatiseerd Archief or PALGA) during the years 1995 to 2008.
Conditions
- Hepatosplenic T-cell Lymphoma
Interventions
- OTHER
-
No intervention
This is an observational study. Medical records of patients with the diagnosis of HSTCL in the PALGA database will be analyzed.
Sponsors & Collaborators
-
Centocor Ortho Biotech Services, L.L.C.
lead INDUSTRY
Principal Investigators
-
Centocor Ortho Biotech Services, L.L.C. Clinical Trial · Centocor Ortho Biotech Services, L.L.C.
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2010-04-30
- Completion
- 2010-04-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
NCT01110733 ·Status: COMPLETED
-
Personalized Therapy of Precursor Lymphoid Neoplasms
NCT01665001 ·Status: UNKNOWN ·Phase: PHASE2
-
Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)
NCT05253118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma
NCT02815137 ·Status: COMPLETED ·Phase: NA
-
Gonadal Toxicity in Women With Hodgkin Lymphoma
NCT01008735 ·Status: UNKNOWN
-
High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant
NCT01941680 ·Status: COMPLETED
-
Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma
NCT01556035 ·Status: COMPLETED ·Phase: PHASE2
-
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
NCT02788916 ·Status: COMPLETED
-
Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies
NCT02315118 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma
NCT01806337 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1
NCT01754311 ·Status: COMPLETED
-
Identification of Occupational Exposures in Acute Hematologic Malignancy
NCT03316209 ·Status: COMPLETED
-
HD18 for Advanced Stages in Hodgkins Lymphoma
NCT00515554 ·Status: COMPLETED ·Phase: PHASE3
-
Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)
NCT01745354 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00147953 ·Status: COMPLETED ·Phase: PHASE2
-
Italian Multicenter Retrospective Observational Study on Transformed Lymphomas
NCT02927756 ·Status: UNKNOWN
-
BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.
NCT06424379 ·Status: ACTIVE_NOT_RECRUITING
-
Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma
NCT06912529 ·Status: TERMINATED ·Phase: PHASE2
-
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
NCT02856646 ·Status: COMPLETED
-
TisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma
NCT04161118 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy
NCT01625741 ·Status: TERMINATED ·Phase: PHASE2
-
Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas
NCT00685997 ·Status: COMPLETED
-
Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
NCT03265158 ·Status: UNKNOWN
-
Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma
NCT02945319 ·Status: COMPLETED
-
Lenalidomide Maintenance Post-debulking in Advanced CTCL
NCT01098656 ·Status: TERMINATED ·Phase: PHASE3